Clinical Trial Update: Buccal Misoprostol Versus IV Oxytocin in Prevention of Postpartum Hemorrhage [Phase 4]

View source ↗

Summary

Phase 4 trial comparing buccal misoprostol to IV oxytocin for prevention of postpartum hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Misoprostol (buccal) (misoprostol)
• oxytocin IV (oxytocin)

Snippet

Sponsor: Assiut University | Conditions: Postpartum Hemorrhage | Phase 4 | Status: COMPLETED